Stay updated on SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial
Sign up to get notified when there's something new on the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page.

Latest updates to the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check23 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe web page has been updated to reflect a new version of the study protocol, with significant changes in the study description and criteria for participation. The study now emphasizes a double-blind, randomized, placebo-controlled design for subcutaneous cohorts.SummaryDifference29%
Stay in the know with updates to SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page.